BLOGS WEBSITE

National Institutes of Health (NIH): Program to Assess the Rigor and Reproducibility of Exosome-Derived Analytes for Cancer Detection (R21)

This opportunity uses the R21 Exploratory/Developmental Research Grants funding mechanism.

This Funding Opportunity Announcement (FOA) encourages research projects that focus on innovative research in the isolation and characterization of exosomes and their cargo for discovery of predictive biomarkers for risk assessment, detection, diagnosis and prognosis of early cancer.

This FOA will promote rigor and reproducibility research in both the isolation of exosomes as well as the computational analysis of the cargo carried in these vesicles.

Companion Schemes

Funding & Duration

Direct costs are limited to US $275,000 (approx AUD $380,000) over an R21 two-year period, with no more than US $200,000 (approx AUD $276,000) in direct costs allowed in any single year.

The maximum project period is 2 years.

Eligibility

Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.

Submission Requirements & Due Dates

Further Information

This entry was posted in Engineering, Computer & Mathematical Sciences, Funding by Award Type, Grants (Project Funds), Health & Medical Sciences, Sciences and tagged . Bookmark the permalink.
 

Comments are closed.